MOORESTOWN, N.J., Aug. 22, 2019 – Tabula Rasa HealthCare, Inc (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced a partnership between its precision dosing software subsidiary DoseMe and Bainbridge Health, a Children’s Hospital of Philadelphia (CHOP) spin-off.
“Managing medications to prevent patient harm and to reduce waste is an incredibly complex and challenging process for hospital clinicians,” said Joseph Kaupp, Co-founder and CEO of Bainbridge Health. “In pursuit of our mission to distill that complexity in order to improve safety and eliminate avoidable cost, it is crucial to partner with mission-aligned industry leaders to continually innovate and drive value. We are privileged to have such a partner in DoseMe and look forward to working together to reduce cost and – most importantly – improve the safety and quality of patient care.”
Bainbridge Health provides clinical solutions based on more than a decade of research and development, including the Med O.S® medication safety and stewardship platform that reduces the risk of medication errors and waste. The partnership will leverage Bainbridge Health’s Med O.S® platform to further enhance medication safety and reduce costs across DoseMe’s partner hospitals.
DoseMeRx is a precision dosing software that was developed specifically for clinical practice. It is a simple, yet powerful tool helping healthcare providers calculate the optimal dose of drugs monitored by therapeutic drug monitoring to streamline operations, reduce adverse drug events, decrease costs, and improve patient outcomes.
“The precision dosing capabilities of DoseMeRx, combined with Bainbridge’s platform, will provide new insights into optimizing intravenous medications in the acute care setting,” said TRHC Chairman and CEO Calvin H. Knowlton, PhD. “By bringing together our technologies, we increase the potential to support healthcare organizations to ensure medications are being appropriately prescribed and delivered to patients in the safest possible manner to improve medication stewardship, reduce adverse drug events and decrease the workload for pharmacy and nursing.”
“We are excited to partner with Bainbridge Health which has a long history and expertise in collaborating with adult and pediatric health systems to enhance medication safety and stewardship,” added Charles Cornish, CEO, DoseMe. “For those hospitals and infusion centers that choose our combined offering, we expect they will see further enhancement in dosing performance while freeing up nurses and pharmacists to practice at the top of their licenses.”
DoseMe is a Tabula Rasa HealthCare Company (NASDAQ: TRHC) and the first company in the world to develop precision dosing software – DoseMeRx – developed specifically for clinical practice. DoseMe’s clinical decision support solutions focus on empowering healthcare providers to optimize dosing of high-risk parenteral medications to streamline operations, reduce adverse drugs events, decrease costs and improve patient outcomes.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize performance to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications, including EireneRx® and MedWise®, provide solutions for a range of payers, providers, and other healthcare organizations. For more information visit: tabularasahealthcare.com
About Bainbridge Health
Bainbridge Health was developed in the Children’s Hospital of Philadelphia and in collaboration with leading adult and pediatric hospitals. Bainbridge helps healthcare organizations unlock the value of their medication data to prevent errors, reduce costs and maintain compliance. The goal is to empower clinical partners to put an end to pivot tables, ad-hoc dashboard requests and manually intensive data-clerking. To learn more about Bainbridge, please visit bainbridgehealth.com/